🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Honeywell (HON) Chosen By KIPIC For PRIZe Project In Kuwait

Published 11/12/2019, 08:22 PM
Updated 07/09/2023, 06:31 AM
ITT
-
HON
-
CSL
-
MIC
-

Honeywell International Inc. (NYSE:HON) recently announced that its business unit, Honeywell Process Solutions (“HPS”), has been chosen by Kuwait Integrated Petroleum Industries Company (“KIPIC”) as the main automation contractor in Kuwait. KIPIC will be using HPS’s front-end engineering design and advanced process control technology for its Petrochemicals and Refinery Integration Al Zour Project (PRIZe) to reach production targets quickly and more effectively.

The project will help to considerably increase the domestic manufacturing capabilities of petrochemicals, aromatics and gasoline in Kuwait. As a matter of fact, when completed, the PRIZe project will be Kuwait’s first integrated refining and petrochemicals complex that will enable KIPIC to cater to the increasing requirements of fuels and petrochemical products in the country.

In addition, the company’s business unit, Honeywell UOP, received a deal from KIPIC to update the Al Zour complex. Notably, Honeywell UOP will be responsible for revising the configuration and capacity of the complex’s gasoline production facilities, key equipment, and catalysts and adsorbents, among others.

Our Take

Honeywell is experiencing strength in its long-cycle businesses in U.S. defense, warehouse automation, process solutions and building technologies, as well as robust demand for aftermarket service business. Strength in the company’s process solutions business driven by solid automation portfolio coupled with strong demand for equipment is likely to keep boosting revenues of its Performance Materials and Technology segment.

However, weakness in the Safety and Productivity Solutions segment on account of lower volumes of sales due to softness in its productivity products business, distributor destocking and fewer large project rollouts remains a concern.

Year to date, the Zacks Rank #3 (Hold) company’s shares have gained 37.7% compared with the industry’s rally of 26.8%.



Key Picks

Some better-ranked stocks from the same space are Carlisle Companies Incorporated (NYSE:CSL) , ITT Inc. (NYSE:ITT) and Macquarie Infrastructure Company (NYSE:MIC) . All these companies carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Carlisle surpassed estimates in each of the preceding four quarters, the average positive earnings surprise being 18.58%.

ITT outpaced estimates in each of the preceding four quarters, the average positive earnings surprise being 7.85%.

Macquarie outpaced estimates twice in the preceding four quarters, the average positive earnings surprise being 5.34%.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



ITT Inc. (ITT): Free Stock Analysis Report

Carlisle Companies Incorporated (CSL): Free Stock Analysis Report

Honeywell International Inc. (HON): Free Stock Analysis Report

Macquarie Infrastructure Company (MIC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.